APP(Abeta40)antibody
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
暂无 | 暂无 | 暂无 | 现货 |
APP(Abeta40)antibody
Cat.#: 2238-1
Rabbit Monoclonal Antibody
Clone ID: EP1876Y
Swiss Prot: P05067
Mol Weight: 4kDa
Size: 100ul
Description
Alzheimer's disease (AD) is characterized by the presence of senile plaques in the brain and blood vessel walls. Amyloid Beta A4 (Aβ4) protein has been found to be the principal constituent of senile plaques of ADs patients (1-2). APP (Abeta40) is proteolytically cleaved to generate the 4 kDa Aβ4 protein. Two variants of Aβ4 can be detected; Aβ-40 short-tailed and Aβ-42 long-tailed (3-4).
Recommended Applications
WB
Applications and Recommended Dilution Factors
WB: 1:1,000 - 10,000
Species Reactivity
Human
Cross reactivity determined by western blot only.
Products Data
A. Western blot analysis on 5ng of recombinant protein using anti-APP (Abeta40) RabMAb (cat. # 2238-1).
B. Western blot analysis on A. Abeta40, B. Abeta42 and C. Abeta38 using anti-APP (Abeta40) RabMAb (cat. # 2238-1).
Specificity
A synthetic peptide corresponding to residues in human APP (Abeta40) was used as immunogen. This antibody specifically recognizes Amyloid Beta Protein (Aβ4) variant Aβ-40.
Storage Condition and Buffer
Store at -20 °C. Buffer: 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.
Alternative Names
APP antibody, AAA antibody, ABETA antibody, ABPP antibody, AD1 antibody, APPI antibody, CTFgamma antibody, CVAP antibody, PN2 antibody, C31 antibody, Gamma-CTF(50) antibody
Description References
1. Glenner, G. G, et al. (1984) Biochem. Biophys. Res. Commun. 120, 885-890
2. Masters, C. L., et al. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 4245-4249
3. Dovey, H., et al. (1993) NeuroReport 4, 1039-1042
4. Vigo-Pelfrey, C., et al (1993) J. Neurochem. 61, 1965-1968
APP(Abeta40)antibody信息由上海希美生物科技有限公司为您提供,如您想了解更多关于APP(Abeta40)antibody报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途